학술논문
Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease
Document Type
Artikel
Author
Source
Diabetes, obesity & metabolism. 25(5):1398-1402
Subject
Language
English
English
English
ISSN
1463-1326